People hospitalized for a debilitating migraine should receive targeted nerve blocks rather than IV opioids, new treatment ...

A new study by Phoenix’s Barrow Neurological Institute is leading to changes in how migraine patients are treated in ...

A new study by Phoenix's Barrow Neurological Institute and the University of Calgary has found which injectable treatments ...

A treatment better known for cosmetic use has a tightly regulated role in migraine care.

When you buy through links on our articles, Future and its syndication partners may earn a commission. A GLP-1 agonist, the same class of drugs as Ozempic, may treat migraine, a study finds. | Credit: ...

Kallyope, a late-stage biotechnology company leveraging unique insights into neural signaling pathways to develop innovative therapies for migraine and metabolism, today announced positive results ...

Recent clinical research has unveiled groundbreaking results for Atogepant, a preventive medication offering new hope for chronic migraine sufferers. The comprehensive study published in Neurology ...

JONESBORO, Ark. (KAIT/EDITED NEWS RELEASE) - A grant is funding research in Region 8 to help those who suffer from migraines. A faculty member at New York Institute of Technology College of ...

The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) - the first and only migraine treatment of its kind to be offered in nasal spray.

The American College of Physicians (ACP) issued a clinical guideline for episodic migraine prevention that varied from what migraine experts recommend. The ACP guideline, published in Annals of ...

The first migraine-specific tool to measure perceived external stigma reveals that patients worry most about misconceptions of secondary gains and minimization of their disease burden, new research ...